Matthew P. Pando
Vorstandsvorsitzender bei Recognify Life Sciences, Inc.
Aktive Positionen von Matthew P. Pando
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Vorstandsvorsitzender | - | - |
| Gründer | - | - | |
| Präsident | - | - | |
Boost Neuroscience, Inc.
 Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Vorstandsvorsitzender | - | - |
| Finanzdirektor/CFO | - | - |
Karriereverlauf von Matthew P. Pando
Ehemalige bekannte Positionen von Matthew P. Pando
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Technik-/Wissenschafts-/F&E-Leiter | 19.07.2010 | 20.12.2012 |
| Corporate Officer/Principal | 19.07.2010 | 19.07.2010 | |
| EUROBIO SCIENTIFIC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2008 | - |
Ausbildung von Matthew P. Pando
| The Salk Institute for Biological Studies | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Frankreich | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Chief Executive Officer | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EUROBIO SCIENTIFIC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Recognify Life Sciences, Inc.
Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Commercial Services |
Boost Neuroscience, Inc.
Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Commercial Services |
- Börse
- Insiders
- Matthew P. Pando
- Erfahrung
